Dextrose; sodium chloride - Generic Drug Details

What are the generic drug sources for dextrose; sodium chloride and what is the scope of freedom to operate?

Dextrose; sodium chloride is the generic ingredient in twenty-five branded drugs marketed by B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Hospira, Abbott, Miles, and Otsuka Icu Medcl, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.

Five suppliers are listed for this compound.

Summary for dextrose; sodium chloride

US Patents:	0
Tradenames:	25
Applicants:	7
NDAs:	32
Finished Product Suppliers / Packagers:	5
Raw Ingredient (Bulk) Api Vendors:	2
Patent Applications:	6
DailyMed Link:	dextrose; sodium chloride at DailyMed

Pharmacology for dextrose; sodium chloride

Drug Class	Osmotic Laxative
Mechanism of Action	Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

Anatomical Therapeutic Chemical (ATC) Classes for dextrose; sodium chloride

A12CA	Sodium
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

B05CB	Salt solutions
B05C	IRRIGATING SOLUTIONS
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

US Patents and Regulatory Information for dextrose; sodium chloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	019631-010	Feb 24, 1988	AP	RX	No	No
B Braun	DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	019631-016	Jan 19, 1990		RX	No	No
Baxter Hlthcare	DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	016689-001	Approved Prior to Jan 1, 1982	AP	RX	No	No
Hospira	DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	018096-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Miles	DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	018400-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Otsuka Icu Medcl	DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	017799-001	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes

Market Dynamics and Financial Trajectory for Dextrose and Sodium Chloride

Last updated: February 15, 2026

Overview

Dextrose (glucose) and sodium chloride are foundational compounds in the pharmaceutical and medical sectors. They are primarily used in intravenous (IV) fluids for hydration, electrolyte balance, and Nutritional support. Production, pricing, and demand patterns influence their market trajectory, fueled by macroeconomic factors, healthcare needs, and regulatory environments.

Market Size and Growth Trends

• The global IV fluids market, which includes dextrose and sodium chloride solutions, was valued at approximately USD 14 billion in 2022. It is expected to grow at a CAGR of 5% between 2023 and 2030 [1].

• Dextrose solutions account for around 40% of this market, with sodium chloride comprising roughly 30%. The remaining segments cover other electrolytes and compounded IV formulations.

• The increasing prevalence of chronic diseases, aging populations, and hospitalizations drive demand for IV therapy, including dextrose and sodium chloride solutions.

Key Market Drivers

• Healthcare Infrastructure Expansion: Growing healthcare facilities, especially in emerging markets, escalate demand for basic IV fluids. Regions such as Asia-Pacific exhibit rapid growth due to rising healthcare investments.

• Chronic Disease Burden: Diseases like diabetes and gastrointestinal disorders necessitate electrolyte and glucose management, sustaining the market.

• COVID-19 Pandemic Impact: The pandemic heightened demand for hydration therapies and electrolyte management in critical care settings, temporarily boosting sales.

• Regulatory Policies: Strict quality standards and approvals influence manufacturing practices, entrance barriers, and market consolidation.

Supply Chain and Production Dynamics

• Major manufacturers include Baxter International, Fresenius Kabi, B. Braun Melsungen AG, and Becton Dickinson (BD). These firms operate extensive manufacturing networks primarily in North America, Europe, and Asia.

• Raw materials are relatively inexpensive but subject to volatility due to global supply chain disruptions, notably in glucose and chemical-grade sodium chloride.

• Production capacity is generally aligned with regional demand; however, shortages can prompt price surges.

Pricing Trends and Financials

• Average wholesale prices for dextrose 5% solutions hover around USD 0.50 per liter, with variations based on quantity and regional regulations.

• Sodium chloride 0.9% solutions typically sell for USD 0.30–0.60 per liter.

• Pricing is influenced by raw material costs, manufacturing scale, regulatory compliance, and competitive dynamics. Price increases of 2–4% annually are common.

Regulatory and Policy Influences

• Ensuring sterility, stability, and compliance with pharmacopeia standards (USP, EP, JP) is mandatory, adding to production costs.

• International bodies such as WHO provide recommendations on standard concentrations and testing, impacting global standards.

Market Challenges and Risks

• Supply Chain Disruptions: Raw material shortages and transportation bottlenecks elevate costs and impact availability.

• Regulatory Hurdles: Varying regional approval processes create barriers to market entry and product registration delays.

• Pricing Pressures: Healthcare payers and governments drive efforts toward cost containment, including negotiation of prices and promoting generic or alternative solutions.

• Environmental Concerns: Waste disposal regulations and sustainability efforts influence manufacturing and disposal costs.

Financial Trajectory

• Established manufacturers project steady revenue growth driven by consistent demand.

• Mergers and acquisitions are common, aiming to increase capacity and market share in key regions.

• Margins remain stable owing to low raw material costs but face pressure from regulatory compliance and quality assurance expenses.

• The rise of generic and hospital-branded products may impact premium pricing strategies.

Key Takeaways

• The dextrose and sodium chloride market is intertwined with the health sector’s growth trajectory, driven by demographic shifts and pandemic-related factors.

• Market size is projected to grow at a compound annual rate of 5%, with stable pricing and ongoing supply chain challenges.

• Regulatory standards influence manufacturing costs and market entry strategies, with international harmonization still evolving.

• Competitive landscape consolidates around major players with extensive manufacturing networks; emerging regional firms face barriers related to quality compliance.

• Cost pressures are counterbalanced by the essential nature of these products and their broad application scope.

FAQs

1. What factors significantly influence the price of IV solutions containing dextrose and sodium chloride?

Price fluctuations are impacted by raw material costs, manufacturing expenses, regulatory compliance, supply chain stability, and regional market conditions.

2. How is the threat of generic competition affecting market leaders?

Generic versions provide cost-effective alternatives, exerting downward pressure on prices and margins. Leading companies focus on quality assurance and strategic expansion.

3. Which regions are experiencing the fastest growth in IV fluid demand?

Emerging markets in Asia-Pacific, especially China and India, exhibit rapid growth due to expanding healthcare infrastructure and rising disease prevalence.

4. What regulatory challenges do manufacturers face?

Achieving compliance with diverse regional standards, obtaining product approvals, and adhering to Good Manufacturing Practices (GMP) influence time-to-market and costs.

5. How might supply chain disruptions affect future market dynamics?

Disruptions can lead to shortages, increased raw material costs, and price volatility, prompting investment in diversified sourcing and capacity expansion.

References

[1] MarketsandMarkets. IV Solutions Market Forecast. 2022.